The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study

被引：0

作者：

Nakamura, Toshinori ^{[1
]}

Furihata, Ryuji ^{[2
]}

Hasegawa, Naomi ^{[3
]}

Kodaka, Fumitoshi ^{[3
,4
]}

Muraoka, Hiroyuki ^{[5
]}

Ichihashi, Kayo ^{[6
]}

Ochi, Shinichiro ^{[7
]}

Numata, Shusuke ^{[8
]}

Tsuboi, Takashi ^{[9
]}

Makinodan, Manabu ^{[10
]}

Iida, Hitoshi ^{[11
]}

Onitsuka, Toshiaki ^{[12
]}

Kashiwagi, Hiroko ^{[3
,13
]}

Takeshima, Masahiro ^{[14
]}

Hashimoto, Naoki ^{[15
]}

Nagasawa, Tatsuya ^{[16
]}

Usami, Masahide ^{[17
]}

Yamagata, Hirotaka ^{[3
,18
]}

Takaesu, Yoshikazu ^{[19
]}

Miura, Kenichiro ^{[3
]}

Matsumoto, Junya ^{[3
]}

Ohi, Kazutaka ^{[20
]}

Yamada, Hisashi ^{[3
,21
]}

Hori, Hikaru ^{[11
]}

Inada, Ken ^{[5
]}

Watanabe, Koichiro ^{[9
]}

Hashimoto, Ryota ^{[3
]}

Yasui-Furukori, Norio ^{[22
]}

机构：

[1] Shinshu Univ, Sch Med, Dept Pathol, 3-1-1 Asahi, Matsumoto 3908621, Japan

[2] Kyoto Univ, Agcy Student Support & Disabil Resources, Yoshida Honmachi, Kyoto 6068501, Japan

[3] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Publ Mental Hlth Res, 4-1-1 Ogawahigashi, Kodaira 1878553, Japan

[4] Jikei Univ, Sch Med, Dept Psychiat, 3-18-13 Nishi Shinbashi, Minato 1058471, Japan

[5] Kitasato Univ, Sch Med, Dept Psychiat, 1-15-1 Kitazato, Sagamihara 2520373, Japan

[6] Univ Tokyo Hosp, Dept Neuropsychiat, 7-3-1 Hongo, Tokyo 1138655, Japan

[7] Ehime Univ, Grad Sch Med, Dept Neuropsychiat Mol & Funct, Shitsukawa, Toon 7910295, Japan

[8] Tokushima Univ, Grad Sch Biomed Sci, Dept Psychiat, 3-8-15 Kuramoto Cho, Tokushima 7708503, Japan

[9] Kyorin Univ, Sch Med, Dept Neuropsychiat, 6-20-2 Shinkawa, Mitaka 1818611, Japan

[10] Nara Med Univ, Dept Psychiat, 840 Shijo Cho, Kashihara 6348522, Japan

[11] Fukuoka Univ, Fac Med, Dept Psychiat, 7-45-1 Nanakuma, Fukuoka 8140180, Japan

[12] NHO Sakakibara Natl Hosp, 777 Sakakibara Cho, Tsu 5141292, Japan

[13] Natl Ctr Psychiat & Neurol, Natl Ctr Hosp, Dept Forens Psychiat, 4-1-1 Ogawahigashi, Kodaira 1878551, Japan

[14] Akita Univ, Grad Sch Med, Dept Neuropsychiat, 1-1-1 Hondo, Akita 0108543, Japan

[15] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Kita 15,Nishi 7, Sapporo 0608638, Japan

[16] Kanazawa Med Univ, Dept Neuropsychiat, 1-1 Daigaku, Uchinada 9200293, Japan

[17] Natl Ctr Global Hlth & Med, Kohnodai Hosp, Dept Child & Adolescent Psychiat, 1-7-1 Kohnodai, Ichikawa 2728516, Japan

[18] Kokoro Hosp Machida, 2140 Kamioyamadamachi, Machida, Japan

[19] Univ Ryukyus, Grad Sch Med, Dept Neuropsychiat, 207 Uehara, Nishihara 9030215, Japan

[20] Gifu Univ, Grad Sch Med, Dept Psychiat, 1-1 Yanagido, Gifu 5011194, Japan

[21] Hyogo Med Univ, Dept Neuropsychiat, 1-1 Mukogawa Cho, Nishinomiya 6638501, Japan

[22] Dokkyo Med Univ, Sch Med, Dept Psychiat, 880 Kitakobayashi, Mibu 3210293, Japan

来源：

BMC PSYCHIATRY | 2024年 / 24卷 / 01期

关键词：

Clinical practice guideline; Psychiatrist; Hypnotic medication; Schizophrenia; Major depressive disorders; BIOLOGICAL TREATMENT; WFSBP GUIDELINES; WORLD FEDERATION; SLEEP; SOCIETIES; RISK;

D O I：

10.1186/s12888-024-05816-x

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Background To examine whether the "Effectiveness of Guideline for Dissemination and Education in psychiatric treatment (EGIUDE)" project affects the rate of prescriptions of hypnotic medication and the type of hypnotic medications prescribed among psychiatrists, for schizophrenia and major depressive disorder in Japan. Methods The EGUIDE project is a nationwide prospective study of evidence-based clinical guidelines for schizophrenia and major depressive disorder in Japan. From 2016 to 2021, clinical and prescribing data from patients discharged from hospitals participating in the EGUIDE project were used to examine hypnotic medication prescriptions The prescribing rate of hypnotics and the prescribing rate of each type of hypnotic (benzodiazepine receptor agonist, nonbenzodiazepine receptor agonist, melatonin receptor agonist, and orexin receptor antagonist) were compared among patients who had been prescribed medication by psychiatrists participating in the EGUIDE project and patients who had been prescribed medication by nonparticipating psychiatrists. Multivariate logistic regression analysis was performed to examine the effect of the EGUIDE project on the prescription of hypnotic medications. Results A total of 12,161 patients with schizophrenia and 6,167 patients with major depressive disorder were included. Psychiatrists participating in the EGUIDE project significantly reduced the rate of prescribing hypnotic medication and benzodiazepine receptor agonists for both schizophrenia (P < 0.001) and major depressive disorder (P < 0.001) patients. Conclusion This is the first study to investigate the educational effects of guidelines for the treatment of psychiatric disorders on psychiatrists in terms of prescribing hypnotic medications to patients. The EGUIDE project may play an important role in reducing hypnotic medication prescription rates, particularly with respect to benzodiazepine receptor agonists. The results suggest that the EGUIDE project may result in improved therapeutic behavior.

引用

页数：10

共 35 条

[11] The validity and reliability of the Japanese version of RU-SATED
Furihata, Ryuji
Tateyama, Yukiko
Nakagami, Yukako
Akahoshi, Toshiki
Itani, Osamu
Kaneita, Yoshitaka
Buysse, Daniel J.
[J]. SLEEP MEDICINE, 2022, 91 : 109 - 114
[12] Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study
Furihata, Ryuji
Otsuki, Rei
Hasegawa, Naomi
Tsuboi, Takashi
Numata, Shusuke
Yasui-Furukori, Norio
Kashiwagi, Hiroko
Hori, Hikaru
Ochi, Shinichiro
Muraoka, Hiroyuki
Onitsuka, Toshiaki
Komatsu, Hiroshi
Takeshima, Masahiro
Hishimoto, Akitoyo
Nagasawa, Tatsuya
Takaesu, Yoshikazu
Nakamura, Toshinori
Asami, Takeshi
Miura, Kenichiro
Matsumoto, Junya
Ohi, Kazutaka
Yasuda, Yuka
Iida, Hitoshi
Ogasawara, Kazuyoshi
Hashimoto, Naoki
Ichihashi, Kayo
Yamada, Hisashi
Watanabe, Koichiro
Inada, Ken
Hashimoto, Ryota
[J]. SLEEP MEDICINE, 2022, 89 : 23 - 30
[13] Association of short sleep duration and short time in bed with depression: A Japanese general population survey
Furihata, Ryuji
Uchiyama, Makoto
Suzuki, Masahiro
Konno, Chisato
Konno, Michiko
Takahashi, Sakae
Kaneita, Yoshitaka
Ohida, Takashi
Akahoshi, Toshiki
Hashimoto, Shu
Akashiba, Tsuneto
[J]. SLEEP AND BIOLOGICAL RHYTHMS, 2015, 13 (02) : 136 - 145
[14] Treating Insomnia Improves Mood State, Sleep, and Functioning in Bipolar Disorder: A Pilot Randomized Controlled Trial
Harvey, Allison G.
Soehner, Adriane M.
Kaplan, Kate A.
Hein, Kerrie
Lee, Jason
Kanady, Jennifer
Li, Descartes
Rabe-Hesketh, Sophia
Ketter, Terence A.
Neylan, Thomas C.
Buysse, Daniel J.
[J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2015, 83 (03) : 564 - 577
[15] World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
Hasan, Alkomiet
Falkai, Peter
Wobrock, Thomas
Lieberman, Jeffrey
Glenthoj, Birte
Gattaz, Wagner F.
Thibaut, Florence
Moeller, Hans-Juergen
[J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2012, 13 (05) : 318 - 378
[16] Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study
Hasegawa, Naomi
Yasuda, Yuka
Yasui-Furukori, Norio
Yamada, Hisashi
Hori, Hikaru
Ichihashi, Kayo
Takaesu, Yoshikazu
Iida, Hitoshi
Muraoka, Hiroyuki
Kodaka, Fumitoshi
Iga, Jun-ichi
Hashimoto, Naoki
Ogasawara, Kazuyoshi
Ohi, Kazutaka
Fukumoto, Kentaro
Numata, Shusuke
Tsuboi, Takashi
Usami, Masahide
Hishimoto, Akitoyo
Furihata, Ryuji
Kishimoto, Taishiro
Nakamura, Toshinori
Katsumoto, Eiichi
Ochi, Shinichiro
Nagasawa, Tatsuya
Atake, Kiyokazu
Kubota, Chika
Komatsu, Hiroshi
Yamagata, Hirotaka
Ide, Kenta
Takeshima, Masahiro
Kido, Mikio
Kikuchi, Saya
Okada, Tsuyoshi
Matsumoto, Junya
Miura, Kenichiro
Shimazu, Taichi
Inada, Ken
Watanabe, Koichiro
Hashimoto, Ryota
[J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2023, 77 (10) : 559 - 568
[17] Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia"
Hashimoto, Ryota
Iga, Junichi
Inada, Ken
Kishi, Taro
Kimura, Hiroshi
Matsuda, Yuki
Miyake, Nobumi
Nemoto, Kiyotaka
Numata, Shusuke
Ochi, Shinichiro
Sato, Hideki
Tarutani, Seiichiro
Uchida, Hiroyuki
[J]. NEUROPSYCHOPHARMACOLOGY REPORTS, 2021, 41 (03) : 266 - 324
[18] Physicians' and patients' choices in evidence based practice - Evidence does not make decisions, people do
Haynes, RB
Devereaux, PJ
Guyatt, GH
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2002, 324 (7350): : 1350 - 1350
[19] Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study
Istvan, Marion
Caillet, Pascal
Rousselet, Morgane
Guerlais, Marylene
Laforgue, Edouard-Jules
Gerardin, Marie
Jolliet, Pascale
Feuillet, Fanny
Victorri-Vigneau, Caroline
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (08) : 3310 - 3319
[20] Japanese Society of Mood Disorders, 2017, Japanese Society of Mood Disorders. Treatment Guideline II, V2

← 1 2 3 4 →